Travelers Compan Financials

TRV

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Travelers Compan (TRV) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TRV FY2025 2026-05-05

Cash conversion and capital rebuilding are strong enough to fund buybacks while the balance sheet quietly gets sturdier.

From FY2023 to FY2025, equity capital rose from $24.9B to $32.9B. Over the same span, debt-to-equity fell from 4.1x to 3.4x despite ongoing buybacks and dividends, meaning retained earnings rebuilt capital faster than payouts and liability growth consumed it; for a company returning cash this aggressively, that is a meaningful strengthening of financial posture.

In FY2025, operating cash flow of $10.6B exceeded net income of $6.3B, and the same relationship held in FY2024. That recurring gap suggests earnings are backed by real cash generation, so capital returns and balance-sheet funding are coming from inflows rather than accounting timing alone, which makes the profit stream look higher quality on a cash basis.

From FY2023 to FY2025, selling and administrative costs held near 12.5% of revenue. Meanwhile, net margin widened from 7.2% to 12.9%, showing the profit improvement did not require a leaner overhead ratio; more revenue was translating into bottom-line earnings instead of just a larger expense base, which is the shape of operating leverage rather than simple cost cutting.

Financial Health Signals

Financial Health Score 45/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Travelers Compan's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Premium Growth

Capital

Combined Ratio

Stability

Piotroski F-Score Partial

5/6

Travelers Compan passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.69x

For every $1 of reported earnings, Travelers Compan generates $1.69 in operating cash flow ($10.6B OCF vs $6.3B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$48.8B

YoY+5.2%

5Y CAGR+8.8%

10Y CAGR+6.2%

Travelers Compan generated $48.8B in revenue in fiscal year 2025. This represents an increase of 5.2% from the prior year.

EBITDA

N/A

Net Income

$6.3B

YoY+25.8%

5Y CAGR+18.4%

10Y CAGR+6.2%

Travelers Compan reported $6.3B in net income in fiscal year 2025. This represents an increase of 25.8% from the prior year.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$842.0M

YoY+20.5%

5Y CAGR+3.2%

10Y CAGR+8.3%

Travelers Compan held $842.0M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

216M

YoY-4.6%

5Y CAGR-3.0%

10Y CAGR-3.1%

Travelers Compan had 216M shares outstanding in fiscal year 2025. This represents a decrease of 4.6% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

12.9%

YoY+2.1pp

5Y CAGR+4.5pp

10Y CAGR+0.1pp

Travelers Compan's net profit margin was 12.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.1 percentage points from the prior year.

Return on Equity

19.1%

YoY+1.2pp

5Y CAGR+9.9pp

10Y CAGR+4.6pp

Travelers Compan's ROE was 19.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.2 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$3.0B

YoY+199.5%

5Y CAGR+36.9%

10Y CAGR-0.5%

Travelers Compan spent $3.0B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 199.5% from the prior year.

Capital Expenditures

N/A

TRV Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$48.8B+5.2%	$46.4B+12.2%	$41.4B+12.1%	$36.9B+5.9%	$34.8B+8.9%	$32.0B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$6.1B+5.2%	$5.8B+12.4%	$5.2B+7.6%	$4.8B+2.8%	$4.7B+3.7%	$4.5B
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$425.0M+8.4%	$392.0M+4.3%	$376.0M+7.1%	$351.0M+3.2%	$340.0M+0.3%	$339.0M
Income Tax	$1.5B+27.7%	$1.2B+210.8%	$380.0M-25.8%	$512.0M-35.7%	$796.0M+47.4%	$540.0M
Net Income	$6.3B+25.8%	$5.0B+67.1%	$3.0B+5.2%	$2.8B-22.4%	$3.7B+35.8%	$2.7B
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$11.9B-4.1%	$12.4B-0.3%	$12.5B+2.9%	$12.1B+2.6%	$11.8B-1.6%	$12.0B+0.9%	$11.9B+5.5%	$11.3B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.5B-0.2%	$1.5B-1.8%	$1.6B+1.7%	$1.5B+5.9%	$1.5B-1.1%	$1.5B+1.0%	$1.5B-1.2%	$1.5B
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$116.0M0.0%	$116.0M+4.5%	$111.0M+12.1%	$99.0M0.0%	$99.0M+1.0%	$98.0M0.0%	$98.0M0.0%	$98.0M
Income Tax	$408.0M-32.8%	$607.0M+33.1%	$456.0M+22.6%	$372.0M+409.6%	$73.0M-85.7%	$512.0M+70.7%	$300.0M+145.9%	$122.0M
Net Income	$1.7B-31.5%	$2.5B+32.2%	$1.9B+25.1%	$1.5B+282.0%	$395.0M-81.0%	$2.1B+65.2%	$1.3B+136.0%	$534.0M
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

TRV Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$143.7B+7.9%	$133.2B+5.7%	$126.0B+8.9%	$115.7B-3.9%	$120.5B+3.2%	$116.8B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$842.0M+20.5%	$699.0M+7.5%	$650.0M-18.6%	$799.0M+5.0%	$761.0M+5.5%	$721.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$4.1B-3.9%	$4.2B+6.5%	$4.0B+0.6%	$4.0B-1.4%	$4.0B+0.8%	$4.0B
Total Liabilities	$110.8B+5.2%	$105.3B+4.2%	$101.1B+7.3%	$94.2B+2.8%	$91.6B+4.6%	$87.6B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$32.9B+18.1%	$27.9B+11.8%	$24.9B+15.6%	$21.6B-25.4%	$28.9B-1.1%	$29.2B
Retained Earnings	$54.9B+10.7%	$49.6B+8.9%	$45.6B+4.8%	$43.5B+4.7%	$41.6B+7.2%	$38.8B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$142.3B-1.0%	$143.7B0.0%	$143.7B+3.5%	$138.9B+2.1%	$136.0B+2.1%	$133.2B-1.0%	$134.6B+4.1%	$129.3B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$615.0M-27.0%	$842.0M+15.5%	$729.0M+10.6%	$659.0M-9.0%	$724.0M+3.6%	$699.0M-9.5%	$772.0M+5.9%	$729.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$4.1B-0.1%	$4.1B-4.8%	$4.3B-0.3%	$4.3B+0.9%	$4.2B+0.3%	$4.2B-0.9%	$4.3B+0.5%	$4.3B
Total Liabilities	$110.3B-0.4%	$110.8B-1.1%	$112.1B+2.5%	$109.4B+1.5%	$107.8B+2.3%	$105.3B-1.5%	$106.9B+2.3%	$104.5B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$32.0B-2.8%	$32.9B+4.1%	$31.6B+7.1%	$29.5B+4.7%	$28.2B+1.2%	$27.9B+0.6%	$27.7B+11.4%	$24.9B
Retained Earnings	$56.4B+2.7%	$54.9B+4.3%	$52.7B+3.2%	$51.0B+2.5%	$49.8B+0.3%	$49.6B+3.9%	$47.8B+2.2%	$46.8B

TRV Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$10.6B+16.9%	$9.1B+17.7%	$7.7B+19.3%	$6.5B-11.1%	$7.3B+11.6%	$6.5B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$7.7B-5.3%	-$7.3B-6.5%	-$6.8B-83.0%	-$3.7B+28.3%	-$5.2B-6.2%	-$4.9B
Financing Cash Flow	-$2.7B-52.4%	-$1.7B-66.2%	-$1.1B+60.6%	-$2.7B-31.0%	-$2.0B-43.9%	-$1.4B
Dividends Paid	$979.0M+2.9%	$951.0M+4.7%	$908.0M+3.8%	$875.0M+0.7%	$869.0M+0.9%	$861.0M
Share Buybacks	$3.0B+199.5%	$1.0B+4.7%	$958.0M-52.1%	$2.0B-7.2%	$2.2B+245.0%	$625.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$2.2B-18.1%	$2.7B-36.5%	$4.2B+81.1%	$2.3B+71.6%	$1.4B-34.1%	$2.1B-46.7%	$3.9B+131.1%	$1.7B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$335.0M+41.7%	-$575.0M+87.4%	-$4.6B-165.3%	-$1.7B-112.4%	-$808.0M+52.3%	-$1.7B+50.1%	-$3.4B-196.7%	-$1.1B
Financing Cash Flow	-$2.1B-14.1%	-$1.8B-554.7%	$402.0M+157.3%	-$702.0M-31.2%	-$535.0M-26.8%	-$422.0M+7.0%	-$454.0M+3.8%	-$472.0M
Dividends Paid	$237.0M-2.1%	$242.0M-2.0%	$247.0M-1.2%	$250.0M+4.2%	$240.0M0.0%	$240.0M+0.8%	$238.0M-2.5%	$244.0M
Share Buybacks	$1.8B+9.2%	$1.6B+164.1%	$619.0M+23.8%	$500.0M+100.0%	$250.0M-2.3%	$256.0M+3.2%	$248.0M-0.4%	$249.0M

TRV Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	12.9%+2.1pp	10.8%+3.5pp	7.2%-0.5pp	7.7%-2.8pp	10.5%+2.1pp	8.4%
Return on Equity	19.1%+1.2pp	17.9%+5.9pp	12.0%-1.2pp	13.2%+0.5pp	12.7%+3.4pp	9.2%
Return on Assets	4.4%+0.6pp	3.8%+1.4pp	2.4%-0.1pp	2.5%-0.6pp	3.0%+0.7pp	2.3%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	3.37-0.4	3.78-0.3	4.06-0.3	4.37+1.2	3.17+0.2	3.00
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	14.3%-5.7pp	20.1%+4.9pp	15.1%+2.7pp	12.4%+9.1pp	3.3%-14.0pp	17.3%+6.8pp	10.6%+5.9pp	4.7%
Return on Equity	5.3%-2.2pp	7.6%+1.6pp	6.0%+0.9pp	5.1%+3.7pp	1.4%-6.1pp	7.5%+2.9pp	4.5%+2.4pp	2.1%
Return on Assets	1.2%-0.5pp	1.7%+0.4pp	1.3%+0.2pp	1.1%+0.8pp	0.3%-1.3pp	1.6%+0.6pp	0.9%+0.5pp	0.4%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	3.45+0.1	3.37-0.2	3.55-0.2	3.70-0.1	3.82+0.0	3.78-0.1	3.86-0.3	4.20
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Allstate Corp ALL

$64.7B

Chubb Limited CB

$137.7B

The Hartford Insurance Group Inc HIG

$38.0B

Progress Corp Oh PGR

$135.6B

W.R Berkley WRB

$26.5B

Frequently Asked Questions

What is Travelers Compan's annual revenue?

Travelers Compan (TRV) reported $48.8B in total revenue for fiscal year 2025. This represents a 5.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Travelers Compan's revenue growing?

Travelers Compan (TRV) revenue grew by 5.2% year-over-year, from $46.4B to $48.8B in fiscal year 2025.

Is Travelers Compan profitable?

Yes, Travelers Compan (TRV) reported a net income of $6.3B in fiscal year 2025, with a net profit margin of 12.9%.

What is Travelers Compan's net profit margin?

Travelers Compan (TRV) had a net profit margin of 12.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Travelers Compan's return on equity (ROE)?

Travelers Compan (TRV) has a return on equity of 19.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Travelers Compan's operating cash flow?

Travelers Compan (TRV) generated $10.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Travelers Compan's total assets?

Travelers Compan (TRV) had $143.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Travelers Compan buy back shares?

Yes, Travelers Compan (TRV) spent $3.0B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Travelers Compan have outstanding?

Travelers Compan (TRV) had 216M shares outstanding as of fiscal year 2025.

What is Travelers Compan's debt-to-equity ratio?

Travelers Compan (TRV) had a debt-to-equity ratio of 3.37 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Travelers Compan's return on assets (ROA)?

Travelers Compan (TRV) had a return on assets of 4.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Travelers Compan's Piotroski F-Score?

Travelers Compan (TRV) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Travelers Compan's earnings high quality?

Travelers Compan (TRV) has an earnings quality ratio of 1.69x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Travelers Compan?

Travelers Compan (TRV) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.